What is Intellia Therapeutics, Inc's Market Cap?

Intellia Therapeutics, Inc's Market Cap is $1.8B, based on as-reported figures from SEC (XBRL) filings.

What is Intellia Therapeutics, Inc's Enterprise Value?

Intellia Therapeutics, Inc's Enterprise Value is $1.3B, based on as-reported figures from SEC (XBRL) filings.

What is Intellia Therapeutics, Inc's Price / Sales?

Intellia Therapeutics, Inc's Price / Sales is 30.0×, based on as-reported figures from SEC (XBRL) filings.

What is Intellia Therapeutics, Inc's EV / Revenue?

Intellia Therapeutics, Inc's EV / Revenue is 22.6×, based on as-reported figures from SEC (XBRL) filings.

What is Intellia Therapeutics, Inc's EV / EBITDA?

Intellia Therapeutics, Inc's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Intellia Therapeutics, Inc's Revenue (TTM)?

Intellia Therapeutics, Inc's Revenue (TTM) is $59.5M, based on as-reported figures from SEC (XBRL) filings.

What is Intellia Therapeutics, Inc's Net Income (TTM)?

Intellia Therapeutics, Inc's Net Income (TTM) is -$400.0M, based on as-reported figures from SEC (XBRL) filings.

What is Intellia Therapeutics, Inc's EBITDA?

Intellia Therapeutics, Inc's EBITDA is -$414.4M, based on as-reported figures from SEC (XBRL) filings.

What is Intellia Therapeutics, Inc's Diluted EPS (TTM)?

Intellia Therapeutics, Inc's Diluted EPS (TTM) is -2.85, based on as-reported figures from SEC (XBRL) filings.

What is Intellia Therapeutics, Inc's EBITDA Margin?

Intellia Therapeutics, Inc's EBITDA Margin is -696.4%, based on as-reported figures from SEC (XBRL) filings.

Intellia Therapeutics, Inc (NTLA) Financial Statements

Intellia Therapeutics, Inc

SIC 2835 · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

FIGI BBG007KC7PC9

XNAS · usd

12.74▲ 0.00 (0.00%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close12.74

Day's Range12.43 – 12.89

52-Week Range7.95 – 28.25

Volume4.1M

Avg Volume3.4M

Share Statistics

Shares Outstanding

Employees377

ExchangeXNAS

Listed2016-05-06

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Intellia Therapeutics, Inc (NTLA)

What is Intellia Therapeutics, Inc's Market Cap?: Intellia Therapeutics, Inc's Market Cap is $1.8B, based on as-reported figures from SEC (XBRL) filings.
What is Intellia Therapeutics, Inc's Enterprise Value?: Intellia Therapeutics, Inc's Enterprise Value is $1.3B, based on as-reported figures from SEC (XBRL) filings.
What is Intellia Therapeutics, Inc's Price / Sales?: Intellia Therapeutics, Inc's Price / Sales is 30.0×, based on as-reported figures from SEC (XBRL) filings.
What is Intellia Therapeutics, Inc's EV / Revenue?: Intellia Therapeutics, Inc's EV / Revenue is 22.6×, based on as-reported figures from SEC (XBRL) filings.
What is Intellia Therapeutics, Inc's EV / EBITDA?: Intellia Therapeutics, Inc's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Intellia Therapeutics, Inc's Revenue (TTM)?: Intellia Therapeutics, Inc's Revenue (TTM) is $59.5M, based on as-reported figures from SEC (XBRL) filings.
What is Intellia Therapeutics, Inc's Net Income (TTM)?: Intellia Therapeutics, Inc's Net Income (TTM) is -$400.0M, based on as-reported figures from SEC (XBRL) filings.
What is Intellia Therapeutics, Inc's EBITDA?: Intellia Therapeutics, Inc's EBITDA is -$414.4M, based on as-reported figures from SEC (XBRL) filings.
What is Intellia Therapeutics, Inc's Diluted EPS (TTM)?: Intellia Therapeutics, Inc's Diluted EPS (TTM) is -2.85, based on as-reported figures from SEC (XBRL) filings.
What is Intellia Therapeutics, Inc's EBITDA Margin?: Intellia Therapeutics, Inc's EBITDA Margin is -696.4%, based on as-reported figures from SEC (XBRL) filings.